NIH to Fund High-Risk Research Alongside Biden’s New Agency

High-risk, high-reward research grants will continue at the National Institutes of Health as a separate biomedical accelerator continues to ramp up, the agency’s second-in-command told Bloomberg Law.

The agency’s existing grant programs will complement the forthcoming work of the Advanced Research Projects Agency for Health, Tara Schwetz, acting principal deputy director of the NIH and former ARPA-H lead at the White House, said in an interview.

“They’re taking different approaches to try to provide the creativity and flexibility to solve particular research challenges,” she said. “These are just two different models of doing that.”

Much of the language used by ...